ICML 2023 Meeting: CFT7455 in NHL Preclinical Presentation
CFT7455: A novel IKZF1/3 degrader, demonstrates potent anti-tumor activity in peripheral and CNS models of non-Hodgkin's lymphoma as a single... | June 16, 2023
Source: marketscreener.com
Stay updated with breaking news from Scottj Eron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CFT7455: A novel IKZF1/3 degrader, demonstrates potent anti-tumor activity in peripheral and CNS models of non-Hodgkin's lymphoma as a single... | June 16, 2023